Search Results for: "U.S. Patent Disclosures"
-
U.S. Patent Disclosures
7,217,807, covering the composition of matter directed at a specific microRNA gene found in HIVBioWorld Today | Tuesday, August 21, 2007 -
U.S. Patent Disclosures
7,173,102, titled "Facially Amphiphilic Polymers and Anti-Infective Agents," which claims compositions of matter for facially amphiphilic polymers and oilgomersBioWorld Today | Friday, March 9, 2007 -
U.S. Patent Disclosures
Isotechnika Inc., of Edmonton, Alberta, received a notice of allowance for a patent covering composition of matter and methods of use claims for TAFA93, a prodrug of rapamycinBioWorld Today | Thursday, February 8, 2007 -
U.S. Patent Disclosures
7,115,396, covering composition of matter claims to Adnectins, a class of targeted biologics with applications in therapeutics and diagnosticsBioWorld Today | Monday, January 8, 2007 -
U.S. Patent Disclosures
7,087,592, covering composition of matter for its purified 2-methoxyestradiol product, Panzem NCD, which is in Phase I and Phase II trials for cancerBioWorld Today | Tuesday, August 29, 2006 -
U.S. Patent Disclosures
7,030,240 B2, which includes claims to the composition of matter, synthesis and use of 5-HT receptor antagonists in physiological conditions associated with serotonin actionBioWorld Today | Friday, July 14, 2006 -
U.S. Patent Disclosures
6,946,445, relating to a broad range of composition of matter claims, including claims that cover its lead cancer compound, CTCE-9908BioWorld Today | Wednesday, October 19, 2005 -
U.S. Patent Disclosures
Acorda Therapeutics Inc., of Hawthorne, N.Y., received a patent on its neuregulins products, covering compositions of matter for the NRG2 family of growth factors, as well as methods of production for NRG2BioWorld Today | Tuesday, October 18, 2005 -
U.S. Patent Disclosures
The patent covers the composition of matter and use for peptides of five to 22 amino acids in length that consist, in large part, of four specific amino acidsBioWorld Today | Monday, August 15, 2005 -
U.S. Patent Disclosures
6,861,415, covering both compositions of matter and methods of use for Progenta, in development for the treatment of uterine fibroids and endometriosisBioWorld Today | Monday, May 2, 2005 -
U.S. Patent Disclosures
6,818,787 covering the composition of matter of its XP13512 compound and related analoguesBioWorld Today | Friday, February 11, 2005 -
U.S. Patent Disclosures
6,761,914 titled "Immunogenic Formulations Comprising Oilbodies," covering composition of matter and methods for preparing and administering immunogenic formulations involving antigen-coated plant and oilbodiesBioWorld Today | Monday, January 31, 2005 -
U.S. Patent Disclosures
6,777,233 covering composition-of-matter claims for the human neural stem cell, including cultures derived from embryonic, fetal, neonatal and adult tissueBioWorld Today | Thursday, November 18, 2004 -
U.S. Patent Disclosures
6,753,329, with claims for the composition of matter of a family of cell-cycle inhibitors that includes RGB-286199BioWorld Today | Monday, June 28, 2004 -
U.S. Patent Disclosures
6,723,700, a composition-of-matter patent for compounds that modulate the family of adhesion molecules known as claudins, which have applications such as enhancing the delivery of drugs to tumors and the inhibition of angiogenesisBioWorld Today | Friday, June 18, 2004 -
U.S. Patent Disclosures
6,716,603 titled "Nucleic Acids Encoding a Chloride Channel Protein," covering the composition of matter of the gene for the human calcium-activated chloride channel and methods for producing the encoded proteinBioWorld Today | Monday, May 10, 2004 -
U.S. Patent Disclosures
6,667,315 covering composition-of-matter claims and compound claims in a series of drugs for cardiovascular and related diseasesBioWorld Today | Friday, March 19, 2004 -
U.S. Patent Disclosures
6,676,929, granting composition-of-matter claims for the chemical structure of its lead compound, MS-325 (gadofosveset), a contrast agent designed for vascular imaging with magnetic resonance angiographyBioWorld Today | Tuesday, January 27, 2004 -
U.S. Patent Disclosures
6,670,344, which grants additional composition-of-matter claims for its lead vascular-targeting compound, Combretastatin A4 Prodrug (CA4PBioWorld Today | Monday, January 26, 2004 -
U.S. Patent Disclosures
6,653,485 covering the compositions of matter for a variety of ortho-substituted chiral biaryl phosphine ligandsBioWorld Today | Tuesday, December 30, 2003
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.